Colorescience® Expands Award-Winning All Calm® Line with New All Calm® Multi-Correction Serum to Address Sensitive Skin Concerns January 25, 2022
TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-100 for the Treatment of Hematologic Malignancies January 24, 2022
XyloCor Therapeutics Expands Leadership Team with Accomplished Pharmaceutical Executives to Accelerate Clinical Development Programs and Drive Corporate Growth January 18, 2022
